PhoenixBio Balance Sheet Health
Financial Health criteria checks 4/6
PhoenixBio has a total shareholder equity of ¥1.8B and total debt of ¥479.0M, which brings its debt-to-equity ratio to 26.7%. Its total assets and total liabilities are ¥2.7B and ¥919.0M respectively. PhoenixBio's EBIT is ¥5.0M making its interest coverage ratio -1.7. It has cash and short-term investments of ¥1.4B.
Key information
26.7%
Debt to equity ratio
JP¥479.00m
Debt
Interest coverage ratio | -1.7x |
Cash | JP¥1.38b |
Equity | JP¥1.80b |
Total liabilities | JP¥919.00m |
Total assets | JP¥2.72b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 6190's short term assets (¥2.1B) exceed its short term liabilities (¥421.0M).
Long Term Liabilities: 6190's short term assets (¥2.1B) exceed its long term liabilities (¥498.0M).
Debt to Equity History and Analysis
Debt Level: 6190 has more cash than its total debt.
Reducing Debt: 6190's debt to equity ratio has increased from 3.1% to 26.7% over the past 5 years.
Debt Coverage: 6190's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 6190 earns more interest than it pays, so coverage of interest payments is not a concern.